TIDMAGR

RNS Number : 1660S

Assura PLC

07 July 2020

7 July 2020

Assura plc

Trading Update

For the first quarter ending 30 June 2020

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter ending 30 June 2020.

Jonathan Murphy, CEO, said:

"We've had an active first quarter, as we continued to deliver strategic and financial progress across all areas of the business, despite these uncertain times for the UK. Our business model remains resilient and robust, as demonstrated by normal patterns of recent rent collections and all our development sites being active in line with social distancing guidelines.

"Our social purpose - to create outstanding primary care properties that sit at the heart of our local communities - has never been more important than it is today, and we are making good progress with our recently launched sixbysix social impact strategy.

"As lockdown restrictions gradually ease, we are working closely with our GP partners to ensure we best support the NHS and respond to evolving market needs as part of the 'new normal'. Primary care will play a crucial role as the UK seeks to rebuild and recover from the COVID-19 crisis and we are engaging with Government to ensure that it remains a key area of investment going forward."

Operational update

   --    Safety and wellbeing of our colleagues, tenants and patients our top priority 

-- Ongoing discussions with our tenants and the NHS on how our buildings can best support the evolving needs of GPs and patients as we gradually move out of the lockdown

   --    All construction sites active with appropriate social distancing measures in place 
   --    June quarter rents being received in line with normal patterns 

Active first quarter

   --    Strong portfolio of 565 properties with current annualised rent roll of GBP110.2 million 

-- Developments at Stafford and Netherfield completed (combined cost GBP11.9 million) - the latter is on track for a BREEAM rating of "Excellent", incorporating a number of sustainable elements including electric vehicle charging points, photovoltaic panels and an air source heat pump

-- Five schemes progressed to on-site, including Stourport in Worcestershire which is part funded by NHS England's Estates and Technology Transformation Fund ("ETTF")

   --    Seven acquisitions completed for combined GBP35 million 

-- Portfolio of 20 assets disposed for GBP17 million, as disclosed in our year end results in May

   --    Two lease regears completed (GBP0.3 million of existing rent) 

-- One capital asset enhancement project completed and three currently on site (combined spend GBP0.6 million)

Strong pipeline for growth

   --    Currently on-site with 18 developments with a total cost of GBP95 million 

-- Immediate development pipeline totalling GBP60 million: schemes which we expect to be on site within 12 months

-- Immediate acquisitions pipeline stands at GBP51 million, which we would normally expect to complete in three-six months

   --    45 lease re-gears covering GBP5.6 million of existing rent roll in the current pipeline 

-- Pipeline of 21 capital asset enhancement projects (projected spend GBP15 million) over the next two years

Robust balance sheet

   --    At 30 June 2020 gross debt stood at GBP767 million with undrawn facilities of GBP300 million 

-- As announced with our year end results in May, the maturity of the revolving credit facility has been extended to November 2025, with the facility reducing from GBP300 million to GBP225 million with effect from May 2021

ENDS

For further information, please contact:

 
 
   Assura plc:                          Tel: 01925 420 680 
   Jayne Cottam, CFO                    Email: Investor@assura.co.uk 
   David Purcell, Head of Financial 
   Reporting 
 
   Finsbury:                            Tel: 0207 251 3801 
   Gordon Simpson                       Email: Assura@Finsbury.com 
   James Thompson 
 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at GBP2,139 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TSTFLFESDDIRIII

(END) Dow Jones Newswires

July 07, 2020 02:00 ET (06:00 GMT)

Grafico Azioni Assura (LSE:AGR)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Assura
Grafico Azioni Assura (LSE:AGR)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Assura